Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent-Related Lower Urinary Symptoms

Table 3

Comparison between group II and III two weeks post insertion of Double-J stent.

	Group II	Group III	𝑃 value
	T group	S group
IPSS Storage symptom score	7.68±3.66	6.62±3.92	0.07
IPSS Voiding symptom score	4.82±2.62	5.10±2.82	0.513
IPSS Total score	12.40±4.5	11.72±4.77	0.352
QoL score	2.80±1.52	3.36±1.77	0.013
OAB-q score	14.93±1.62	12.42±1.42	0.000
VAPS score	3.23±1.23	4.36±1.44	0.000

IPSS: International Prostate Symptom Score; QoL: Quality of Life; OAB-q: Overactive Bladder Questionnaire; VAPS: Visual Analogue Pain Scale.